BZAI

BZAI remains in a Stage 4 decline with a clear sequence of lower highs and lower lows. Price is trading below all key EMAs and is being rejected at the 9/21 EMA zone. Short-term momentum favors selling into dynamic resistance within the declining EMA regime. The medium-term bias stays bearish under persistent distribution, making execution now appropriate. A sustained close and acceptance above the 9EMA and 21EMA would invalidate this bearish stance.

• ↑$50M confirmed contract win; NeoTensr partnership opens $70M Asia-Pacific opportunity.
• ↑Q1 2026 revenue hit $2.7M (+170% YoY); management forecasts continued breakout growth.
• ↓Q1 net loss of $22.7M, down from $147.8M prior year but still substantial.